Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials-Reference-Cited by-同舟云学术

Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials

Published:2017-11-08 Issue:1 Volume:168 Page:35-41
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lynce Filipa^ORCID,Blackburn Matthew J.,Cai Ling,Wang Heping,Rubinstein Larry,Harris Pamela,Isaacs Claudine,Pohlmann Paula R.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-017-4563-3/fulltext.html

Reference28 articles.

1. Itoh K, Sasaki Y, Miyata Y et al (1994) Therapeutic response and potential pitfalls in phase I clinical trials of anticancer agents conducted in Japan. Cancer Chemother Pharmacol 34:451–454

2. Estey E, Hoth D, Simon R et al (1986) Therapeutic response in phase I trials of antineoplastic agents. Cancer Treat Rep 70:1105–1115

3. Decoster G, Stein G, Holdener EE (1990) Responses and toxic deaths in phase I clinical trials. Ann Oncol 1:175–181

4. Bachelot T, Ray-Coquard I, Catimel G et al (2000) Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials. Ann Oncol 11:151–156

5. Han C, Braybrooke JP, Deplanque G et al (2003) Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents. Br J Cancer 89:1166–1171

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes for Patients With Metastatic Breast Cancer Treated With Immunotherapy Agents in Phase I Clinical Trials;Frontiers in Oncology;2021-03-17

2. Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center;Cancer Medicine;2020-10-16

3. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin;International Journal of Molecular Sciences;2020-04-23

4. Predictive Values of Preoperative Index Analysis in Patients with Esophageal Squamous Cell Carcinoma;Communications in Computer and Information Science;2020

5. An isomiR expression panel based novel breast cancer classification approach using improved mutual information;BMC Medical Genomics;2018-12